Opinion|Videos|July 23, 2026 (Updated: July 16, 2026)
Defining Alzheimer's Disease Agitation: Diagnostic Criteria, Symptoms, and Disease Course
Kavita Nair leads the discussion on defining Alzheimer's disease agitation.
Advertisement
Episodes in this series
Kavita Nair leads the discussion on defining Alzheimer's disease agitation. Anton Porsteinsson outlines IPA provisional diagnostic criteria (2015, made permanent 2023): agitation must occur in context of cognitive impairment, include ≥1 of 3 behavioral manifestations (excessive motor activity, verbal aggression, physical aggression), persist ≥2 weeks, cause distress and disability, and not be attributable to another condition. Agitation can present as early as pre-dementia stages (MCI) and typically peaks during moderate to early severe stages.
Advertisement
Related to this article
ASPEN links green sputum to neutrophils and exacerbations; brensocatib (DPP1) lowers purulence, while meta-analysis supports fewer flare-ups in bronchiectasis.
Experts at CHEST 2026 urge pulmonologists to keep lung cancer in mind for younger patients who never smoked, to order screening and biomarker testing themselves, and to advocate for patients' access to care.
Phentolamine 0.75% (Ryzumvi) won FDA approval for presbyopia based on the phase 3 VEGA-2 and VEGA-3 trials.
Satralizumab, a first-in-class IL-6 receptor inhibitor, was approved for adults with thyroid eye disease based on the phase 3 SatraGO program.
A higher PNR is associated with lower odds of MASLD and advanced liver fibrosis, but further studies are needed to validate findings.
Speakers at CHEST 2026 walked through the first CHEST guideline for non-CF adult bronchiectasis, including which preventive therapy to start first.
SaTScan detects an acute HCV outbreak cluster in California, showing the potential of automated surveillance, though real-time testing is needed.
Genetic analysis finds 125 loci shared by insomnia and CRP, with Mendelian randomization favoring an effect from insomnia liability to inflammation.
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Ryzumvi for Presbyopia, Expanding its Label
2
Patents, Rebates, and a Policy Patchwork Keep Inhalers Costly, Panelists Say
3
How Flatiron Health’s Network Chief Is Building the Future For (and With) Community Oncology Practices
4
FDA Grants Accelerated Approval to Dostarlimab for dMMR Rectal Cancer
5